Latest Europe News

Page 20 of 133
Dyno Nobel has signed a binding agreement to sell its Phosphate Hill fertiliser business to Mayfair Australia Corporation, marking a strategic pivot to focus solely on its explosives operations. The deal, expected to complete in Q3 FY26, includes deferred payments and regulatory conditions.
Maxwell Dee
Maxwell Dee
9 Mar 2026
Provaris Energy has successfully raised $1.325 million through an oversubscribed placement, aiming to advance its 2026 development milestones in hydrogen and carbon dioxide storage technologies.
Maxwell Dee
Maxwell Dee
5 Mar 2026
Little Green Pharma Ltd (ASX: LGP) has proposed a full acquisition of Cannatrek Ltd via a scheme of arrangement, creating a vertically integrated medicinal cannabis group with pro forma FY26 revenues exceeding AUD 100 million. The scheme, supported by an independent expert, offers liquidity and strategic growth opportunities amid regulatory and market risks.
Ada Torres
Ada Torres
5 Mar 2026
Advanced Braking Technology Ltd has reported a record half-year performance for 1H26, driven by strong demand for its SIBS Failsafe braking systems and progress in autonomous braking technology.
Victor Sage
Victor Sage
5 Mar 2026
Control Bionics has secured a key regulatory milestone with its NeuroNode device now eligible for reimbursement under Germany’s statutory health insurance, paving the way for expanded European distribution.
Ada Torres
Ada Torres
4 Mar 2026
Regener8 Resources has acquired 100% of the Srebrenica North Project, a polymetallic silver-lead-zinc asset in a historically rich European mining district, positioning itself amid active regional exploration and production hubs.
Maxwell Dee
Maxwell Dee
3 Mar 2026
Neuren Pharmaceuticals’ partner Acadia Pharmaceuticals is seeking a re-examination of the European Medicines Agency’s refusal to approve trofinetide for Rett syndrome, aiming to overturn the setback and bring the treatment to European patients.
Victor Sage
Victor Sage
3 Mar 2026
Element 25 Limited is advancing its Butcherbird Manganese Mine expansion and developing a US-based battery-grade manganese refinery, supported by major funding and strategic partnerships.
Maxwell Dee
Maxwell Dee
3 Mar 2026
Avecho Biotechnology has completed recruitment for the interim analysis cohort of its pivotal Phase III trial for a CBD insomnia treatment, with results expected in June 2026. This milestone could significantly de-risk the program and unlock major market opportunities.
Ada Torres
Ada Torres
2 Mar 2026
Norwood Systems Limited reported a significant revenue increase for the half-year ended December 2025, alongside a widening net loss and strategic progress with Tier-1 telecom customers. The company secured additional funding and advanced its AI-driven voice platforms in collaboration with global hyperscalers.
Sophie Babbage
Sophie Babbage
27 Feb 2026
Vmoto Limited reported an 18% revenue decline to $46.8 million and a $9.9 million net loss in FY25, while accelerating its transformation into a full-stack electric mobility solutions provider with new global partnerships and product innovations.
Victor Sage
Victor Sage
27 Feb 2026
Provaris Energy reported a 59% increase in its half-year loss to $2.09 million, driven by higher project development costs amid progress in hydrogen and carbon capture technologies. The company raised over $3.5 million in capital and is advancing key milestones for its hydrogen shipping and liquid CO2 tank projects.
Maxwell Dee
Maxwell Dee
27 Feb 2026